NCT00110630View on ClinicalTrials.gov

Smoking Treatment of Prisoners

PHASE3CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions
Tobacco Use CessationTobacco Use Disorder
Interventions
BEHAVIORAL

10-week smoking cessation group therapy combined with NicoDerm CQ

Trial Locations (1)

23298

Virginia Commonwealth University, Richmond

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

National Institute on Drug Abuse (NIDA)

NIH